Here are five things to know:
1. The company expects to grant underwriters a 30-day option to purchase additional shares of its common stock.
2. LDR plans to use net proceeds to continue expanding the sales and marketing efforts in the Untied States and internationally, including the Mobi-C launch in the United States.
3. The company also plans to use proceeds of research and development as well as potential complementary technology acquisitions.
4. The company will also repay around $18.2 million of debt with the proceeds.
5. Piper Jaffray and William Blair are acting as the joint book-running managers for the offering.
More articles on orthopedic devices:
SeaSpine launches Ventura NanoMetalene spine device: 5 key points
K2M, InVivo Therapeutics, Zimmer & more—19 key notes
Global sports medicine market to reach $53.6B by 2022: 6 key trends
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
